KFDA announces results of vaccine re-evaluation study
Published: 2003-12-30 06:59:00
Updated: 2003-12-30 06:59:00
Adverse reaction events have been observed from domestic vaccine preparations produced by eight pharmaceutical firms including Boryung Biopharma and Dongshin Pharm, according to a report released by the Korea Food and Drug Administration.
The KFDA said that as concern about both safety and eff...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
